Henry Lu
Corporate Officer/Principal chez WUXI APPTEC CO., LTD.
Profil
Henry Lu is Vice President & Head-Biology at WuXi AppTec Co., Ltd.
Dr. Lu previously occupied the position of Senior Director-Infectious Diseases at Rigel Pharmaceuticals, Inc., Principal Scientist at Novartis Corp.
and Adjunct Associate Professor at The University of California, San Francisco.
He received an undergraduate degree from Fudan University and a doctorate from Academia Sinica.
Postes actifs de Henry Lu
Sociétés | Poste | Début |
---|---|---|
WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 03/08/2011 |
Anciens postes connus de Henry Lu
Sociétés | Poste | Fin |
---|---|---|
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
Formation de Henry Lu
Fudan University | Undergraduate Degree |
Academia Sinica | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
RIGEL PHARMACEUTICALS, INC. | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |